对结果测量工具的系统审查是基于证据选择这些工具的重要工具。COSMIN(基于共识的健康测量指标选择标准)制定了一项全面而广泛的指南,对结果测量仪器进行系统审查,但是在发表的评论中经常缺少关键信息。这就妨碍了对成果测量仪器质量的评价,影响知识用户关于其适当性的决定,并损害了评论结果的可重复性和可解释性。为了方便,透明,以及对结果测量工具的系统评价的一致报告,将扩展PRISMA(系统评价和荟萃分析的首选项目报告)2020指南:PRISMA-COSMIN指南.
PRISMA-COSMIN指南将根据EQUATOR(增强卫生研究的质量和透明度)网络报告指南制定的建议制定。首先,将通过环境文献扫描和专家咨询创建候选报告项目列表。第二,一项国际德尔菲研究将由系统综述作者进行,生物统计学家,流行病学家,心理测量医生/临床医生,报告指南开发人员,杂志编辑和患者,看护者,和公众。德尔菲小组成员将以5分制对候选项目进行评级,建议其他候选项目,并就项目措辞和可理解性提供反馈。第三,PRISMA-COSMIN指南和用户手册草案将通过将其应用于几个疾病领域的系统评价来评估其相关性,全面性,和可理解性,以及可用性和用户满意度。第四,将举行一次共识会议,通过圆桌讨论和投票最终确定PRISMA-COSMIN准则。最后,将编写用户手册,并通过出版物传播PRISMA-COSMIN最终指南,会议,时事通讯,和相关网站。此外,将邀请相关期刊和组织认可和实施PRISMA-COSMIN。在整个项目中,将进行评估,以确定涉及患者/公共合作伙伴并采用虚拟流程的障碍和促进者。
PRISMA-COSMIN指南将确保成果测量仪器的系统评价报告是完整和翔实的,增强它们的可重复性,易用性,和吸收。
Systematic reviews of outcome measurement instruments are important tools in the evidence-based selection of these instruments. COSMIN (COnsensus-based Standards for the selection of health Measurement INstruments) has developed a comprehensive and widespread guideline to conduct systematic reviews of outcome measurement instruments, but key information is often missing in published reviews. This hinders the appraisal of the quality of outcome measurement instruments, impacts the decisions of knowledge users regarding their appropriateness, and compromises reproducibility and interpretability of the reviews\' findings. To facilitate sufficient, transparent, and consistent reporting of systematic reviews of outcome measurement instruments, an extension of the PRISMA (Preferred Reporting of Items for Systematic reviews and Meta-Analyses) 2020 guideline will be developed: the PRISMA-COSMIN guideline.
The PRISMA-COSMIN guideline will be developed in accordance with recommendations for reporting guideline development from the EQUATOR (Enhancing the QUAlity and Transparency Of health Research) Network. First, a candidate reporting item list will be created through an environmental literature scan and expert consultations. Second, an international Delphi study will be conducted with systematic review authors, biostatisticians, epidemiologists, psychometricians/clinimetricians, reporting guideline developers, journal editors as well as patients, caregivers, and members of the public. Delphi panelists will rate candidate items for inclusion on a 5-point scale, suggest additional candidate items, and give feedback on item wording and comprehensibility. Third, the draft PRISMA-COSMIN guideline and user manual will be iteratively piloted by applying it to systematic reviews in several disease areas to assess its relevance, comprehensiveness, and comprehensibility, along with usability and user satisfaction. Fourth, a consensus meeting will be held to finalize the PRISMA-COSMIN guideline through roundtable discussions and voting. Last, a user manual will be developed and the final PRISMA-COSMIN guideline will be disseminated through publications, conferences, newsletters, and relevant websites. Additionally, relevant journals and organizations will be invited to endorse and implement PRISMA-COSMIN. Throughout the project, evaluations will take place to identify barriers and facilitators of involving patient/public partners and employing a virtual process.
The PRISMA-COSMIN guideline will ensure that the reports of systematic reviews of outcome measurement instruments are complete and informative, enhancing their reproducibility, ease of use, and uptake.